Neogene Therapeutics

Neogene Therapeutics company information, Employees & Contact Information

Updated June 2026

Quick answer

Neogene Therapeutics is a Biotechnology Research company and founded in 2018. It has approximately 61 employees on record. Contact data was last refreshed in June 2026. Find Neogene Therapeutics's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Neogene Therapeutics is a global, clinical-stage biotechnology company pioneering the discovery, development, and manufacturing of next-generation engineered T cell receptor (TCR) therapies targeting a broad spectrum of solid cancers. With offices in Santa Monica, CA and Amsterdam, the Netherlands, Neogene is aiming to change the paradigm of treatment for solid cancers. Neogene is a member of the AstraZeneca Group.

Company Details

Employees
61
Founded
2018
Address
Science Park 106, Amsterdam,north Holland 1098,netherlands
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Amsterdam, North Holland
Looking for a particular Neogene Therapeutics employee's phone or email?

Neogene Therapeutics Questions

News

Neogen Announces Sale of Cleaners & Disinfectants Business - Business Wire

Neogen Announces Sale of Cleaners & Disinfectants Business Business Wire

Neogen® launches Igenity® BCHF to mitigate Bovine Congestive Heart Failure risk - Beef Magazine

Neogen® launches Igenity® BCHF to mitigate Bovine Congestive Heart Failure risk Beef Magazine

AstraZeneca to Acquire Neogene Therapeutics for $320M - citybiz

AstraZeneca to Acquire Neogene Therapeutics for $320M citybiz

Business Spotlight Series: Biotech - Santa monica.gov

Business Spotlight Series: Biotech Santa monica.gov

Neogen® MDS Awarded Contract from USDA Food Safety and Inspection Service - PR Newswire

Neogen® MDS Awarded Contract from USDA Food Safety and Inspection Service PR Newswire

Neogene Therapeutics Raises $110 Million Series A Financing to Develop Next-Generation Fully Personalized Neo-Antigen T Cell Receptor (TCR) Therapies - DutchNews.nl

Neogene Therapeutics Raises $110 Million Series A Financing to Develop Next-Generation Fully Personalized Neo-Antigen T Cell Receptor (TCR) Therapies DutchNews.nl

Neogene Therapeutics Announces Approval of Clinical Trial Application for its First Phase 1 Trial of Novel, Fully-Individualized TCR Therapy to Treat Advanced Solid Tumors - Business Wire

Neogene Therapeutics Announces Approval of Clinical Trial Application for its First Phase 1 Trial of Novel, Fully-Individualized TCR Therapy to Treat Advanced Solid Tumors Business Wire

Top Neogene Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant